Revium Rx. Stock

Stocks

Market Closed - OTC Markets 22:43:00 05/08/2025 HKT			5-day change	1st Jan Change
0.5200 ^USD	+73.33%		-68.86%	-

08-14	Revium Rx. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-22	Revium Rx. Announces Resignation of Inna Martin from Director, Chief Operating Officer and President, Effective June 16, 2026	CI

08-14	Revium Rx. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-22	Revium Rx. Announces Resignation of Inna Martin from Director, Chief Operating Officer and President, Effective June 16, 2026	CI
06-01	Revium Rx. Announces CFO Changes, Effective May 27, 2026	CI
05-15	Revium Rx. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-21	Revium Rx. Appoints Amir Avraham as Permanent Chief Executive Officer, Effective as of February 1, 2026	CI
04-21	Revium Rx. Appoints Shlomi Schwartzblat as Director and Chairman of the Board, Effective April 14, 2026	CI
04-01	Revium Rx. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-31	Revium Rx. Auditor Raises 'Going Concern' Doubt	CI
01-17	Revium Rx. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
21/10/25	Revium Recovery Inc. Advances Toward Phase 1 Clinical Development of Nano-Mupirocin to Combat Antibiotic-Resistant Infections	CI
04/10/25	Revium Rx. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
14/02/25	Revium Rx. has filed an IPO in the amount of $5 million.	CI
04/02/25	Revium Recovery Inc. completed the acquisition of LipoVac, Ltd.	CI

21/10/25	Revium Rx Advances Toward Phase 1 Clinical Development of Nano-Mupirocin to Combat Antibiotic-Resistant Infections	GL
05/02/25	Revium Rx (RVRC) Completes Acquisition of LipoVation Ltd.	GL
21/12/22	Revium Recovery, Inc. Announces Letter of Intent to Acquire LipoVac Ltd	AQ
20/12/22	Revium Recovery, Inc. Announces Letter of Intent to Acquire LipoVac Ltd.	AQ
18/12/20	Correction: REVIUM RECOVERY ACQUIRES ANTI-ADDICTION REHABILITATION BUSINESS	GL

Manager	Title	Age	Since
Amir Avraham CEO	Chief Executive Officer	-	22/05/2025
Igor Bluvstein DFI	Director of Finance/CFO	46	27/05/2026
Inna Martin CEO	Chief Executive Officer	51	-

Director	Title	Age	Since
Inna Martin BRD	Director/Board Member	51	-
Matti Munk BRD	Director/Board Member	-	-
Yoram Druker BRD	Director/Board Member	-	-

Employees

Sector

Date	Price	Change	Volume

Real-time OTC Markets